Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine
US5765548A · kind A · utility
30Cited by
5References
28Claims
0Family size
Inventor
Key dates
| Filing date | May 7, 1996 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | May 7, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2250/00
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The administration of nitric oxide in controlled doses to horses during high intensity exercise is described. The nitric oxide is beneficial to prevent exercised induced pulmonary hemorrhaging by reducing pulmonary artery pressure with a concomitant compensating reduction in pulmonary vascular resistance. The nitric oxide is either administered to the equine through inhalation during exercise or via a stand alone nitric oxide gas source followed by an intramuscular injection of a nitric oxide augmenter prior to exercise.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.